Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis.

Giovanni CaocciOlga MulasMario AnnunziataLuigiana LucianoMassimiliano BonifacioEster Maria OrlandiPatrizia PregnoSara GalimbertiAntonella Russo RossiElisabetta AbruzzeseAlessandra IurloBruno MartinoNicola SgherzaGianni BinottoFausto CastagnettiAntonella GozziniClaudio Fozza Monica BocchiaAnna SicuranzaFabio StagnoFabio EfficaceEmilio UsalaFiorenza De GregorioLuigi ScaffidiChiara ElenaFrancesca PirilloClaudia BaratèMalgorzata Monika TrawinskaDaniele CattaneoClaudia LabateGabriele GugliottaMatteo MolicaGiorgina SpecchiaGiorgio La NasaRobin FoàMassimo Breccia

Published in: American journal of hematology (2018)

Keyphrases

chronic myeloid leukemia
risk factors
primary care
healthcare
oxidative stress
bioinformatics analysis
quality improvement